Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Peptic Ulcer

  Free Subscription

Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 64 articles:
HTML format

Single Articles

    February 2024
  1. KIM NH, Chang Y, Ryu S, Sohn CI, et al
    Impact of metabolic unhealthiness and its changes on the risk of erosive esophagitis: a cohort study.
    J Gastroenterol Hepatol. 2024 Feb 21. doi: 10.1111/jgh.16519.
    PubMed     Abstract available

  2. SIMADIBRATA DM, Lesmana E, Fass R
    Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials.
    J Gastroenterol Hepatol. 2024 Feb 14. doi: 10.1111/jgh.16486.
    PubMed     Abstract available

  3. AYAR MS, Baydin A, Ustaoglu M, Caliskan F, et al
    Inferior vena cava collapsibility index and stroke volume as predictors of blood transfusion in upper gastrointestinal bleeding in the emergency department.
    J Gastroenterol Hepatol. 2024 Feb 9. doi: 10.1111/jgh.16500.
    PubMed     Abstract available

    January 2024
  4. SIMADIBRATA DM, Lesmana E, Fass R
    A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.
    J Gastroenterol Hepatol. 2024 Jan 23. doi: 10.1111/jgh.16475.
    PubMed     Abstract available

  5. ZHUANG Q, Liao A, He Q, Liu C, et al
    The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
    J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1111/jgh.16471.
    PubMed     Abstract available

  6. MUFTAH M, Hartnett DA, Flanagan R, Redd WD, et al
    Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis.
    J Gastroenterol Hepatol. 2024 Jan 7. doi: 10.1111/jgh.16469.
    PubMed     Abstract available

    November 2023
  7. SUN Y, Zhang A, Zuo M, Chen J, et al
    A pharmacovigilance study of association between proton-pump inhibitors and rhabdomyolysis event based on FAERS database.
    J Gastroenterol Hepatol. 2023 Nov 14. doi: 10.1111/jgh.16411.
    PubMed     Abstract available

  8. BAILEY ME, Borges LF, Goldberg HJ, Hathorn KE, et al
    Abnormal bolus reflux on impedance-pH testing independently predicts 3-year pulmonary outcome and mortality in pulmonary fibrosis.
    J Gastroenterol Hepatol. 2023;38:1998-2005.
    PubMed     Abstract available

  9. NABI Z, Ramchandani M, Basha J, Inavolu P, et al
    Per-oral endoscopic myotomy in cases with prior Heller's myotomy: Outcomes at a median follow-up of 5 years.
    J Gastroenterol Hepatol. 2023;38:2035-2039.
    PubMed     Abstract available

    October 2023
  10. SHIMAMURA Y, Inoue H, Tanabe M, Ushikubo K, et al
    Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study.
    J Gastroenterol Hepatol. 2023 Oct 3. doi: 10.1111/jgh.16370.
    PubMed     Abstract available

    September 2023
  11. ZENG SY, Wang J, Liu J, Lin MJ, et al
    Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.
    J Gastroenterol Hepatol. 2023 Sep 13. doi: 10.1111/jgh.16348.
    PubMed     Abstract available

    August 2023
  12. YU Y, Liao Z, Jiang X, Pan J, et al
    The use of magnet-controlled capsule endoscopy as the initial diagnostic tool in patients with acute upper gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2023 Aug 3. doi: 10.1111/jgh.16310.
    PubMed     Abstract available

  13. OHKI D, Tsuji Y, Kuroda R, Ushiku T, et al
    Gastrointestinal: A case of significant esophageal ulceration due to oral iron pill therapy.
    J Gastroenterol Hepatol. 2023;38:1241.

    July 2023
  14. YOU N, Chen Y, Yan X, Gu B, et al
    Persistent Helicobacter pylori infection leads to elevated fasting plasma glucose level: A retrospective cohort study based on a nondiabetes Chinese population.
    J Gastroenterol Hepatol. 2023 Jul 4. doi: 10.1111/jgh.16275.
    PubMed     Abstract available

    June 2023
  15. EL HAGE CHEHADE N, Fu Y, Ghoneim S, Shah S, et al
    Association between obstructive sleep apnea and gastroesophageal reflux disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2023 Jun 10. doi: 10.1111/jgh.16245.
    PubMed     Abstract available

    April 2023
  16. GULIYARA MA, Ermerak G, Levy M, Koo JH, et al
    Frailty predicts mortality in patients with Upper Gastrointestinal bleed: A prospective cohort study.
    J Gastroenterol Hepatol. 2023 Apr 1. doi: 10.1111/jgh.16188.
    PubMed     Abstract available

    March 2023
  17. CHANG A, Rugivarodum M, Pungpipattrakul N, Akarapatima K, et al
    Role of Oral Iron Supplementation for Anemia Secondary to Acute Nonvariceal Upper Gastrointestinal Bleeding: A Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2023 Mar 30. doi: 10.1111/jgh.16185.
    PubMed     Abstract available

  18. SARUTA Y, Watanabe K, Tsuji T, Takahashi Y, et al
    Vonoprazan poses no additional risk of developing Clostridioides difficile infection compared to proton pump inhibitors.
    J Gastroenterol Hepatol. 2023 Mar 7. doi: 10.1111/jgh.16169.
    PubMed     Abstract available

  19. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.

    February 2023
  20. DUNNE CL, Kaur S, Delacruz B, Bresee LC, et al
    30-day Readmission Rates Among Upper Gastrointestinal Bleeds: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2023 Feb 20. doi: 10.1111/jgh.16153.
    PubMed     Abstract available

  21. JO SY, Noh JH, Cha B, Ahn JY, et al
    Clinical outcomes of Dieulafoy's lesion compared to peptic ulcer in upper gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2023 Feb 5. doi: 10.1111/jgh.16139.
    PubMed     Abstract available

  22. ZHANG X, Sun K, Tang C, Cen L, et al
    LECT2 modulates dendritic cell function after Helicobacter pylori infection via the CD209a receptor.
    J Gastroenterol Hepatol. 2023 Feb 5. doi: 10.1111/jgh.16138.
    PubMed     Abstract available

    November 2022
  23. JAVIER BF, Nicolas S, Virginia C, Karina E, et al
    Low-grade duodenal eosinophilia is associated with cagA in Helicobacter pylori related dyspepsia.
    J Gastroenterol Hepatol. 2022 Nov 5. doi: 10.1111/jgh.16051.
    PubMed     Abstract available

  24. PARK SK, Kim MH, Jung JY, Oh CM, et al
    Change in smoking status and its relation to the risk of gastroduodenal ulcer in Korean men.
    J Gastroenterol Hepatol. 2022;37:2091-2097.
    PubMed     Abstract available

    October 2022
    A Comparison of Efficacy and Safety of Potassium Channel Acid Blocker and Proton Pump Inhibitor in Gastric Acid-related Diseases: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2022 Oct 1. doi: 10.1111/jgh.16017.
    PubMed     Abstract available

    September 2022
  26. TAN ND, Liu XW, Liu CX, Li SB, et al
    The efficacy of keverprazan for duodenal ulcer: a phase II randomized, double-blind, parallel-controlled trial.
    J Gastroenterol Hepatol. 2022 Sep 6. doi: 10.1111/jgh.16000.
    PubMed     Abstract available

    August 2022
  27. LI K, Cheng X, Jin R, Han T, et al
    The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury.
    J Gastroenterol Hepatol. 2022 Aug 8. doi: 10.1111/jgh.15973.
    PubMed     Abstract available

  28. EUSEBI LH, Telese A, Cirota GG, Haidry R, et al
    Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022;37:1507-1516.
    PubMed     Abstract available

    July 2022
  29. JUNG YS, Kim S, Kim HY, Noh SJ, et al
    7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15939.
    PubMed     Abstract available

  30. WANG JW, Hsu PI, Lin MH, Kao JY, et al
    The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection - A real-world clinical experience.
    J Gastroenterol Hepatol. 2022 Jul 11. doi: 10.1111/jgh.15942.
    PubMed     Abstract available

    June 2022
  31. OUYANG Y, Wang M, Xu YL, Zhu Y, et al
    Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Jun 18. doi: 10.1111/jgh.15917.
    PubMed     Abstract available

    May 2022
  32. KAKIUCHI T, Okuda M, Matsuo M, Fujimoto K, et al
    Smart Gene as an effective noninvasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.
    J Gastroenterol Hepatol. 2022 May 13. doi: 10.1111/jgh.15887.
    PubMed     Abstract available

  33. PARK DH, In Seo S, Lee KJ, Kim J, et al
    Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: a nationwide population-based and multicenter cohort study using a common data model.
    J Gastroenterol Hepatol. 2022 May 2. doi: 10.1111/jgh.15879.
    PubMed     Abstract available

  34. XIAO Y, Wu JCY, Lu CL, Tseng PH, et al
    Clinical practice guidelines for esophageal ambulatory reflux monitoring in Chinese adults.
    J Gastroenterol Hepatol. 2022;37:812-822.
    PubMed     Abstract available

    April 2022
  35. HUANG Y, Chen J, Ding Z, Liang X, et al
    Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2022 Apr 17. doi: 10.1111/jgh.15864.
    PubMed     Abstract available

    March 2022
  36. HOU X, Meng F, Wang J, Sha W, et al
    Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
    J Gastroenterol Hepatol. 2022 Mar 27. doi: 10.1111/jgh.15837.
    PubMed     Abstract available

  37. KUDO Y, Kudo SE, Miyachi H, Ichimasa K, et al
    Changes in halitosis value before and after Helicobacter pylori eradication: A single-institutional prospective study.
    J Gastroenterol Hepatol. 2022 Mar 24. doi: 10.1111/jgh.15835.
    PubMed     Abstract available

  38. SCHUBERT JP, Woodman RJ, Mangoni AA, Rayner CK, et al
    Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?
    J Gastroenterol Hepatol. 2022 Mar 21. doi: 10.1111/jgh.15832.
    PubMed     Abstract available

  39. YANG W, Yusufu Y, Wang C
    Gastrointestinal: A rare case of upper gastrointestinal bleeding: Splenosis mimicking gastric varices.
    J Gastroenterol Hepatol. 2022 Mar 1. doi: 10.1111/jgh.15795.

    February 2022
  40. KHAN R, Saha S, Gimpaya N, Bansal R, et al
    Outcomes for upper gastrointestinal bleeding during the first wave of the COVID-19 pandemic in the Toronto area.
    J Gastroenterol Hepatol. 2022 Feb 16. doi: 10.1111/jgh.15804.
    PubMed     Abstract available

  41. TERASAKI K, Ueno A, Mizuno C, Shima T, et al
    Gastrointestinal: Pembrolizumab-induced gastric ulcer occurring as an immune-related adverse event.
    J Gastroenterol Hepatol. 2022 Feb 9. doi: 10.1111/jgh.15788.

    December 2021
  42. MANEERATTANAPORN M, Pittayanon R, Patcharatrakul T, Bunchorntavakul C, et al
    Thailand Guideline 2020 for Medical Management of Gastroesophageal Reflux Disease (GERD).
    J Gastroenterol Hepatol. 2021 Dec 14. doi: 10.1111/jgh.15758.

  43. KOUNTOURAS J, Doulberis M, Polyzos SA, Kazakos E, et al
    Impact of Helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies.
    J Gastroenterol Hepatol. 2021 Dec 10. doi: 10.1111/jgh.15753.

  44. REN S, Cai P, Liu Y, Wang T, et al
    Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021 Dec 3. doi: 10.1111/jgh.15751.
    PubMed     Abstract available

    October 2021
  45. YONGWATANA K, Harinwan K, Chirapongsathorn S, Opuchar K, et al
    Curcuma longa Linn Versus Omeprazole in Treatment of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2021 Oct 15. doi: 10.1111/jgh.15705.
    PubMed     Abstract available

  46. BUNCHORNTAVAKUL C, Buranathawornsom A
    Randomized Clinical Trial: 7-day Vonoprazan-based versus 14-day Omeprazole-based Triple Therapy for Helicobacter pylori.
    J Gastroenterol Hepatol. 2021 Oct 7. doi: 10.1111/jgh.15700.
    PubMed     Abstract available

    August 2021
  47. UENO M, Mano T, Kayahara T, Mizuno M, et al
    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: It's time to step forward.
    J Gastroenterol Hepatol. 2021 Aug 8. doi: 10.1111/jgh.15652.

  48. SIKAVI DR, Cai JX, Carroll TL, Chan WW, et al
    Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2021;36:2076-2082.
    PubMed     Abstract available

    July 2021
  49. CHO JH, Jin SY, Park S
    Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti-Helicobacter pylori antibody results.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15630.
    PubMed     Abstract available

  50. CHEN Y, Xu C, Xu H, Chen W, et al
    Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: a retrospective cohort study based on a healthy Chinese population.
    J Gastroenterol Hepatol. 2021 Jul 1. doi: 10.1111/jgh.15603.
    PubMed     Abstract available

  51. SUNG JJ
    Clopidogrel is no better or worse than aspirin when combined with proton pump inhibitors in the prevention of major adverse event. Is the jury out?
    J Gastroenterol Hepatol. 2021;36:1733-1734.

    June 2021
  52. HUSSEIN M, Alzoubaidi D, O'Donnell M, de la Serna A, et al
    Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15579.
    PubMed     Abstract available

  53. GINGOLD-BELFER R, Niv Y, Schmilovitz-Weiss H, Levi Z, et al
    Susceptibility-Guided vs Empirical Treatment for Helicobacter pylori infection: a Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2021 Jun 11. doi: 10.1111/jgh.15575.
    PubMed     Abstract available

  54. HORII T, Suzuki S, Takano C, Shibuya H, et al
    Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15572.
    PubMed     Abstract available

    May 2021
  55. JEON HJ, Moon HS, Kwon IS, Kang SH, et al
    Which scoring system should be used for non-variceal upper gastrointestinal bleeding? Old or New?
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15555.
    PubMed     Abstract available

    March 2021
  56. QIAO C, Li Y, Liu J, Ji C, et al
    Clarithromycin versus furazolidone for naive Helicobacter pylori infected patients in a high clarithromycin resistance area.
    J Gastroenterol Hepatol. 2021 Mar 10. doi: 10.1111/jgh.15468.
    PubMed     Abstract available

  57. KODAMA M, Okimoto T, Mizukami K, Hirashita Y, et al
    Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: a long-term prospective follow-up study.
    J Gastroenterol Hepatol. 2021 Mar 3. doi: 10.1111/jgh.15477.
    PubMed     Abstract available

    February 2021
  58. AKADA J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, et al
    Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
    J Gastroenterol Hepatol. 2021 Feb 20. doi: 10.1111/jgh.15467.
    PubMed     Abstract available

    January 2021
  59. KATO M, Hayashi Y, Nishida T, Oshita M, et al
    Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    J Gastroenterol Hepatol. 2021 Jan 5. doi: 10.1111/jgh.15396.
    PubMed     Abstract available

  60. NIIKURA R, Aoki T, Kojima T, Kawahara T, et al
    Natural history of upper and lower gastrointestinal bleeding in hemodialysis patients: A dual-center long-term cohort study.
    J Gastroenterol Hepatol. 2021;36:112-117.
    PubMed     Abstract available

    November 2020
  61. YANG SC, Wu CK, Tai WC, Liang CM, et al
    Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
    J Gastroenterol Hepatol. 2020 Nov 28. doi: 10.1111/jgh.15360.
    PubMed     Abstract available

  62. SCHUBERT JP, Gehlert J, Rayner CK, Roberts-Thomson IC, et al
    Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15352.
    PubMed     Abstract available

    October 2020
  63. GINGOLD-BELFER R, Niv Y, Levi Z, Boltin D, et al
    Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2020 Oct 10. doi: 10.1111/jgh.15294.
    PubMed     Abstract available

  64. TANG C, Zhu Y, Yang X, Xu B, et al
    Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting.
    J Gastroenterol Hepatol. 2020;35:1720-1730.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.